首页> 美国卫生研究院文献>Indian Heart Journal >Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients

【2h】

Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients

机译：一项随机对照试验比较了初次血脂异常患者每日和隔日服用阿托伐他汀的疗效及其与血清羟甲基戊二酰辅酶A还原酶水平的相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Data regarding efficacy comparison of daily regimen (DR) versus every other day regimen (EODR) atorvastatin therapy is not validated by estimation of serum hydroxymethylglutaryl-CoA reductase (HMGCR) levels and HMGCR correlation with lipid indices.

机译：关于每日方案（DR）与隔日方案（EODR）阿托伐他汀治疗的疗效比较数据尚未通过估算血清羟甲基戊二酰辅酶A还原酶（HMGCR）水平以及HMGCR与脂质指数的相关性来验证。

著录项

期刊名称 Indian Heart Journal
作者
Manoj Kumar; Harmeet Singh Rehan; Raman Puri; Madhur Yadav; Lalit Kumar Gupta;
展开▼
作者单位

展开▼
年(卷),期 2018(70),Suppl 3
年度 2018
页码 -1
总页数 4
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Atorvastatin; Every other day atorvastatin; Dyslipidemia; Hydroxymethylglutaryl-CoA reductase enzyme;

机译：阿托伐他汀;隔日阿托伐他汀;血脂异常;羟甲基戊二酰辅酶A还原酶;

相似文献

外文文献
中文文献
专利

1. Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in na?ve dyslipidemic patients [J] . Manoj Kumar, Harmeet Singh Rehan, Raman Puri, Indian heart journal . 2018,第6期

机译：比较初次血脂异常患者每日和隔日服用阿托伐他汀的疗效及其与血清羟甲基戊二酰辅酶A还原酶水平的相关性的随机对照试验
2. Tolerability and effectiveness of every-other-day atorvastatin compared to daily atorvastatin in patients with muscle symptoms: A randomized controlled clinical trial [J] . Nirmala Wijekoon, Sanjeewa Wijekoon, Uditha Bulugahapitiya, Contemporary Clinical Trials Communications . 2020,第a期

机译：与肌肉症状患者的日常阿托伐他汀相比，每隔一天的阿托伐他汀的可耐受性和有效性：随机对照临床试验
3. Assessing the efficacy and safety of pitavastatin compared to atorvastatin in dyslipidemic patients: a double blind randomized controlled trial [J] . Chetan Y. Patil, Mirza Shiraz Baig, Sudhkar M. Doifode International Journal of Basic & Clinical Pharmacology . 2016,第3期

机译：评估匹伐他汀与阿托伐他汀相比在血脂异常患者中的疗效和安全性：一项双盲随机对照试验
4. Impact of Complementary Therapies via Mobile Technologies on Icelandic Same Day Surgical Patients' Reports of Anxiety, Pain and Self-Efficacy in Healing: A Randomized Controlled Trial in Process [C] . Margaret M. Hansen MEDINFO . 2013

机译：互补疗法通过移动技术对冰岛同日外科患者的影响焦虑，痛苦和自我疗效愈合中的报告：过程中的随机对照试验
5. A Pilot Randomized Controlled Trial Comparing the Efficacy of Problem-Solving Therapy to Enhanced Treatment as Usual for Reducing High Blood Pressure [D] . Greenberg, Lauren Miriam 2015

机译：解决问题的疗法与通常用于降低高血压的强化治疗的疗效比较的试验性随机对照试验
6. Tolerability and effectiveness of every-other-day atorvastatin compared to daily atorvastatin in patients with muscle symptoms: A randomized controlled clinical trial [O] . Nirmala Wijekoon, Sanjeewa Wijekoon, Uditha Bulugahapitiya, 2020

机译：与肌肉症状患者的每日阿托伐他汀相比每隔一天的阿托伐他汀的耐受性和有效性：随机对照临床试验
7. Assessing the efficacy and safety of pitavastatin compared to atorvastatin in dyslipidemic patients: a double blind randomized controlled trial [O] . Chetan Patil, Mirza Baig, Sudhkar Doifode 2016

机译：评估脱伐他汀与血液血症患者的阿托伐他汀的疗效和安全性：双盲随机对照试验

Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients

摘要

著录项

相似文献

相关主题

期刊订阅